Iranian Journal of Pediatrics

Published by: Kowsar

Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome

Ravish Singhal 1 , * , Sadbhavna Pandit 1 and Neeraj Dhawan 1
Authors Information
1 Department of Pediatrics, Government Multispecialty Hospital, Chandigarh, India
Article information
  • Iranian Journal of Pediatrics: April 28, 2015, 25 (2)
  • Published Online: April 18, 2015
  • Article Type: Research Article
  • Received: February 8, 2015
  • Revised: February 15, 2015
  • Accepted: March 10, 2015
  • DOI: 10.5812/ijp.510

To Cite: Singhal R, Pandit S, Dhawan N. Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic Syndrome, Iran J Pediatr. 2015 ; 25(2):-. doi: 10.5812/ijp.510.

Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Indian Pediatric Nephrology Group IAOP. Consensus statement on management of steroid sensitive nephrotic syndrome. Indian Pediatr. 2001; 38(9): 975-86[PubMed]
  • 2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003; 362(9384): 629-39[DOI][PubMed]
  • 3. Bagga A, Srivastava RN. Pediatric Nephrology. 2005; : 159-200
  • 4. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001; 59(6): 2126-33[DOI][PubMed]
  • 5. Bagga A, Mantan M. Nephrotic syndrome in children. Indian J Med Res. 2005; 122(1): 13-28[PubMed]
  • 6. Pais P. Nelson Textbook of Pediatrics. 2011; : 1801-4
  • 7. Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int. 1981; 20(6): 765-71[PubMed]
  • 8. Hagg R, Portman RJ, Milliner D. Evaluation and management of proteinuria and nephrotic syndrome in children. Recommendations from a Pediatric Nephrology Panel established at the National Kidney Foundation Conference on proteinuria, albuminuria risk, assessment, detection and elimination (PARADE). Pediatrics. 2000; 106: 1242–9
  • 9. Bagga A, Hari P, Srivastava RN. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol. 1999; 13(9): 824-7[DOI][PubMed]
  • 10. Indian Pediatric Nephrology Group IAOP, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, et al. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2008; 45(3): 203-14[PubMed]
  • 11. Nayak S, Acharjya B. Deflazacort versus other glucocorticoids: a comparison. Indian J Dermatol. 2008; 53(4): 167-70[DOI][PubMed]
  • 12. Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P. A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol. 1997; 11(4): 418-22[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments